针对所有高血压患者进行原醛症筛查:势在必行

Screening for primary aldosteronism in all hypertensive patients:inevitable strategy

原发性醛固酮增多症(primary hyperaldosteronism,PA)占所有高血压患者的5%~10%。筛查为诊断PA的关键步骤。本文根据国内外最新证据,提出了目前筛查PA存在的一些主要问题,并给出建议,以期指导临床工作和提高PA检出率。

Primary hyperaldosteronism(PA) accounts for 5% to 10% of all hypertensive patients. Screening is the first step of the diagnostic process of PA. Based on the latest evidences both at home and abroad,this manuscript puts forward the existing problems of screening and gives suggestions,in order to guide clinical work and improve the detection rate of PA.